Bank of America’s Nutex Health NUTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$858K Buy
9,027
+3,101
+52% +$380K ﹤0.01% 4592
2025
Q4
$976K Sell
5,926
-5,119
-46% -$679K ﹤0.01% 4542
2025
Q3
$1.14M Buy
11,045
+7,330
+197% +$719K ﹤0.01% 5237
2025
Q2
$462K Buy
3,715
+1,211
+48% +$156K ﹤0.01% 5755
2025
Q1
$118K Buy
2,504
+430
+21% +$21K ﹤0.01% 6424
2024
Q4
$65.7K Buy
2,074
+2,043
+6,590% +$58.2K ﹤0.01% 6553
2024
Q3
$673 Buy
31
+1
+3% +$14 ﹤0.01% 7321
2024
Q2
$176 Sell
30
-45
-60% -$324 ﹤0.01% 7582
2024
Q1
$1.07K Sell
75
-3
-4% -$60 ﹤0.01% 7195
2023
Q4
$2.11K Sell
78
-10,985
-99% -$343K ﹤0.01% 7124
2023
Q3
$335K Buy
11,063
+10,522
+1,945% +$508K ﹤0.01% 5587
2023
Q2
$34.2K Sell
541
-100
-16% -$8.58K ﹤0.01% 6575
2023
Q1
$97.1K Sell
641
-534
-45% -$108K ﹤0.01% 6266
2022
Q4
$335K Buy
1,175
+977
+493% +$188K ﹤0.01% 5637
2022
Q3
$45K Buy
198
+148
+296% +$62.8K ﹤0.01% 6723
2022
Q2
$24K Buy
+50
New +$58.9K ﹤0.01% 7126

Other funds holding NUTX

Bank of America's NUTX Position: Q1 2026 in Review

Bank of America increased its Nutex Health (NUTX) stake by 52% in Q1 2026, buying an estimated $380K and bringing the position to 9,027 shares worth $858K. The position accounts for ﹤0.01% of the portfolio, ranked #4592.

Bank of America first reported a position in NUTX in Q2 2022 and has held it in 16 quarters since. The position peaked at $1.14M in Q3 2025. 129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • Bank of America held 9,027 shares of Nutex Health worth $858K as of Q1 2026.
  • Bank of America bought 3,101 Nutex Health shares in Q1 2026, an estimated $380K.
  • Nutex Health made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4592 holding.
  • Bank of America first reported a position in Nutex Health in Q2 2022 and has held it in 16 quarters since.
  • Bank of America's Nutex Health position peaked at $1.14M in Q3 2025.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.